B
BioMarin Pharmaceutical
BMRN · NASDAQ · Healthcare
$63.74
+$2.36 (+3.70%) today
Loading live data...
Market Cap
$12.33B
24h Volume
$222.5M
P/E Ratio
172.5
52w High
$64.08
52w Low
$49.67
Est. AI Revenue
12%
Loading chart data...
7-Day Sparkline (Static)
About BioMarin Pharmaceutical
Rare disease biotech using AI for gene therapy optimization, patient identification algorithms, and computational protein engineering for enzyme replacement.
CEO: Alexander Hardy
Founded: 1997
HQ: San Rafael, California
Employees: 3,221
Performance
24 Hours+3.70%
7 Days+6.19%
30 Days+6.28%
1 Year+7.19%